美迪凯控股子公司拟引入战投富浙绍芯

Core Viewpoint - The company Medike (688079) has approved a capital increase for its subsidiary, Zhejiang Medike Optical Semiconductor Co., Ltd., by introducing a strategic investor, Zhejiang Fuzhe Shaoxin Integrated Circuit Industry Fund Partnership (Limited Partnership), with an investment of 200 million yuan at a pre-investment valuation of 2.18 billion yuan [1] Group 1: Capital Increase Details - The strategic investor will hold an 8.40% stake in Medike Optical Semiconductor after the capital increase [1] - The funds from this capital increase will primarily be used for the main business of Medike Optical Semiconductor and other purposes agreed upon by the investor [1] - The capital raised cannot be transferred to Medike or its affiliates for any purpose [1] Group 2: Financial Performance - In 2024, Medike Optical Semiconductor is projected to have a revenue of 313 million yuan and a net loss of 42.47 million yuan [2] - For the first three quarters of 2025, the company reported a revenue of 264 million yuan and a net loss of 65.77 million yuan [2] Group 3: Strategic Implications - The capital increase is expected to enhance the financial strength of Medike Optical Semiconductor, meeting the capital needs for its business development and creating synergistic effects [2] - The capital increase agreement includes provisions for potential share buybacks, allowing Medike to repurchase shares from the investor within four years under certain conditions [2] - Medike remains the controlling shareholder of Medike Optical Semiconductor post-capital increase, and the subsidiary will continue to be included in Medike's consolidated financial statements [3] Group 4: Business Strategy - Medike focuses on product differentiation and is actively improving its business and product structure, investing in semiconductor optoelectronics, micro-nano circuits (mainly MEMS), semiconductor packaging and testing, precision optics, micro-nano optics, and smart terminal manufacturing [3] - The company is increasing the proportion of its products in semiconductor optoelectronics, micro-nano circuits, and semiconductor packaging and testing, optimizing its customer structure and enhancing the semiconductor device industry chain [3]